A recent article in the U.S. News by Dennis Thompson states that four specific genes have been discovered that could help us understand more about stomach cancer. Testing four different genetic mutations could enable doctors to help find a direct treatment that could aggressively treat conditions, such as surgery or chemotherapy.
Today, most gastric cancers are treated the same way. Recent research has identified different molecular differences, which may enable scientists to tailor treatment to a specific person's mutation. During this study, they looked at 21 genes in tumors taken from 87 patients who had already undergone chemotherapy. By comparing the genes within the patients, they found that BRCA2, CDH1, RHOA, and TP53 changes were likely to lead to cancer. Researchers are trying to match the findings to establish an affordable test to discover individuals with high-risk patterns. Identifying these patterns could help us lead in the right direction in tumor biology.
No comments:
Post a Comment